DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Insulin signaling pathway	R-HSA-74752	map04910	eticlopride	4993	drug-path
Pancreatic cancer	R-HSA-9700206	map05212	eticlopride	4993	drug-path
Prostate cancer	R-HSA-2990872	map05215	eticlopride	4993	drug-path
Acute myeloid leukemia	R-HSA-9680350	map05221	eticlopride	4993	drug-path
Hedgehog signaling pathway	R-HSA-5358351	map04340	eticlopride	4993	drug-path
Melanoma	Q9UHD0-PRO_0000015379	map05218	eticlopride	4993	drug-path
Long-term potentiation	R-HSA-9620244	map04720	eticlopride	4993	drug-path
Asthma	R-HSA-444620	map05310	eticlopride	4993	drug-path
MAPK signaling pathway	R-HSA-9652817	map04010	eticlopride	4993	drug-path
Endometrial cancer	R-HSA-2077421	map05213	eticlopride	4993	drug-path
Allograft rejection	R-HSA-9679028	map05330	eticlopride	4993	drug-path
Type I diabetes mellitus	R-HSA-5683209	map04940	eticlopride	4993	drug-path
Chronic myeloid leukemia	R-HSA-9680350	map05220	eticlopride	4993	drug-path
Olfactory transduction	R-HSA-9751605	map04740	beta-escin	16211024	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	beta-escin	16211024	drug-path
ECM-receptor interaction	R-HSA-373711	map04512	beta-escin	16211024	drug-path
Parkinson's disease	R-HSA-1643685	0	beta-escin	16211024	drug-path
Ribosome	R-HSA-5368277	map03010	beta-escin	16211024	drug-path
Chemokine signaling pathway	R-HSA-168638	map04062	beta-escin	16211024	drug-path
Alzheimer's disease	R-HSA-1643685	0	lycorine	202225	drug-path